NIH launches $215m partnership for cancer immunotherapy strategies
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
List view / Grid view
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
TK216-vincristine combination appears to halt the ability of Ewing sarcoma to grow and progress...
Alcohol aversion drug disulfiram may combat chemotherapy resistance in non-small cell lung cancer...
Research shows the Parkinson's disease drug carbidopa displays significant anticancer effects in human cell lines...
Researchers find ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer...
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment...
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy, a current study has investigated the underlying mechanisms of this action...
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
Research published in The Journal of Experimental Medicine suggests potential treatment for glioblastoma
Researchers have recently discovered an immunotherapy that uses existing cancer drugs in a whole new way...
Brazilian researchers have investigated whether cisplatin and 5-FU would interfere with the protein pRB...
A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK...